Pet Pharm Biotech Co., Ltd. (TPEX:7762)
41.25
-5.40 (-11.58%)
At close: Nov 20, 2026
| Market Cap | 2.40B -33.4% |
| Revenue (ttm) | 266.86M +40.1% |
| Net Income | 47.45M +114.5% |
| EPS | 0.81 +87.0% |
| Shares Out | 58.09M |
| PE Ratio | 51.10 |
| Forward PE | n/a |
| Dividend | 0.25 (0.60%) |
| Ex-Dividend Date | Jul 20, 2026 |
| Volume | 141,362 |
| Open | 46.70 |
| Previous Close | 46.65 |
| Day's Range | 41.20 - 46.70 |
| 52-Week Range | 41.20 - 72.22 |
| Beta | 0.69 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Mar 19, 2027 |